news
Professor Ulrich G Steidl received the National Institute of Cancer's…
28 October 2021 | By Anna Begley (Drug Target Review)
Professor Ulrich G Steidl received the National Institute of Cancer's Outstanding Investigator Award to study myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).